3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Leukemia
17
Lymphoma, Non-Hodgkin
16
Sarcoma
9
Leukemia, Myeloid, Acute
9
Hodgkin Disease
9
Hematologic Neoplasms
9
Neuroblastoma
8
Neoplasms
8
Myelodysplastic Syndromes
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Burkitt Lymphoma
6
Osteosarcoma
5
Melanoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Breast Neoplasms
5
Rhabdoid Tumor
4
Retinoblastoma
4
Multiple Myeloma
4
Medulloblastoma
4
Lymphoma, Large B-Cell, Diffuse
4
Wilms Tumor
3
Recurrence
3
Neoplasms, Germ Cell and Embryonal
3
Myeloproliferative Disorders
3
Hepatoblastoma
3
Graft vs Host Disease
3
Interventions
fludarabine
4
fludarabine phosphate
3
Cyclophosphamide
3
thymoglobulin
1
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Erythrocyte Count
1
Dexamethasone
1
Clofarabine
1
Busulfan
1
Bortezomib
1
Blood Transfusion
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thalassemia
×
Mesna
×
Clear all
NCT00578292
2020-05-01
THALLO
Baylor College of Medicine
Phase NA
Terminated
10 enrolled
15 charts